This is the first of six sessions in the Resiliency-Informed Substance Use Prevention Learning Series.
Click here to access session 2.
Learning Objectives:
By the end of the session, participants will be able to:
- Outline the current state of the opioid crisis, and how it’s changed over time presenting unique challenges and opportunities.
- Recognize the need for substance use prevention and resilience.
- How a program with a mixed methods approach is changing how we view substance use prevention.
- Demonstrate how stories of loss can mobilize communities to make an impact.
Presented by:
- Cammie Wolf Rice is a renowned author, activist, and speaker dedicated to ending the Opioid Epidemic. After the tragic loss of her son Christopher in 2016, Cammie turned her pain into purpose by founding CWC Alliance, a 501(c)(3) nonprofit dedicated to substance use prevention by empowering individuals to lead safer, healthier, and more resilient lives through opioid education, mental wellness support, and effective pain management strategies. Cammie is the author of The Flight: My Opioid Journey a memoir detailing her personal and transformative journey through the opioid crisis, a testament to her resilience and commitment to advocacy.
- Fabricia Prado, LCSW is a trilingual clinician, speaker, and trainer specializing in trauma treatment, ACEs, and resilience building. She is the founder of Prado Counseling and Consulting and a certified Community Resiliency Model (CRM) teacher. With expertise in EMDR, mindfulness, and trauma-sensitive approaches, she provides trauma-informed training and practical interventions to support healing and resilience.
Funding for this activity was made possible in whole or in part by the Nevada Department of Health and Human Services (DHHS) Director’s Office through the Fund for a Resilient Nevada, established in Nevada Revised Statutes 433.712 through 433.744. The opinions, findings, conclusions, and recommendations expressed in our courses are those of the author(s) and do not necessarily represent the official views of the Nevada Opioid Center of Excellence or its funders.